Ligand Pharmaceuticals Inc (LGND)
Accumulated OCI
$4.48M
Quarterly · Period ending: · USD
LGND Accumulated OCI
Latest reported$4.48Mperiod ending
Latest reported$4.48Mperiod ending
LGND Quarterly Accumulated OCI ($0.00 → $4.48M)
Quarterly accumulated oci
High-resolution chart · PNG
LGND accumulated oci history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Accumulated OCI (USD) |
|---|---|
| 4,476,000 | |
| 5,390,000 | |
| 8,455,000 | |
| 9,322,000 | |
| 8,494,000 | |
| -1,563,000 | |
| -5,942,000 | |
| 1,746,000 | |
| -935,000 | |
| -910,000 | |
| -817,000 | |
| -944,000 | |
| -967,000 | |
| -935,000 | |
| -984,000 | |
| -1,060,000 | |
| -1,066,000 | |
| -1,031,000 | |
| -917,000 | |
| -875,000 | |
| -861,000 | |
| -856,000 | |
| -801,000 | |
| -1,441,000 | |
| -2,310,000 | |
| -4,867,000 | |
| -216,000 | |
| -1,493,000 | |
| -542,000 | |
| -503,000 | |
| -1,024,000 | |
| -64,000 | |
| -151,000 | |
| -286,000 | |
| 2,486,000 | |
| 3,335,000 | |
| 3,059,000 | |
| 3,105,000 | |
| 2,743,000 | |
| 3,652,000 | |
| 3,745,000 | |
| 3,568,000 | |
| 4,903,000 | |
| 5,558,000 | |
| 11,265,000 | |
| 9,334,000 | |
| 4,953,000 | |
| 3,543,000 | |
| 5,041,000 | |
| 10,943,000 | |
| 2,914,000 | |
| 2,201,000 | |
| 1,395,000 | |
| 1,166,000 | |
| -4,881,000 | |
| -4,800,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 5,000 | |
| 31,000 | |
| 76,000 | |
| 885,000 | |
| 1,021,000 | |
| 513,000 | |
| 317,000 | |
| 94,000 | |
| 11,000 | |
| 81,000 | |
| 103,000 | |
| -28,000 | |
| -43,000 | |
| 9,000 | |
| -110,000 | |
| -155,000 | |
| -140,000 | |
| -481,000 | |
| -138,000 | |
| 30,000 | |
| 1,021,000 | |
| 490,000 | |
| -182,000 | |
| -420,000 | |
| -738,000 | |
| 229,000 | |
| -123,000 | |
| -127,000 | |
| -53,000 | |
| -66,000 | |
| -88,000 | |
| -46,000 | |
| -61,000 | |
| -43,000 | |
| -60,000 | |
| -72,000 | |
| -395,000 | |
| -678,000 | |
| -974,000 |